What is Ultralytics?
Ultralytics stands at the forefront of artificial intelligence, specializing in the development of transformative, open-source computer vision tools. The company is globally acclaimed as the creator of YOLO, the world's most widely adopted real-time object detection framework. This technology democratizes advanced AI, making sophisticated, easy-to-use tools accessible to a broad spectrum of users, ranging from individual developers to large-scale enterprise innovators. The company's commitment to open-source principles fosters widespread adoption and continuous improvement within the AI community.
How much funding has Ultralytics raised?
Ultralytics has raised a total of $30M across 1 funding round:
Series A
$30M
Series A (2025): $30M with participation from Elephant and SquareOne Venture Capital
Key Investors in Ultralytics
Elephant
Elephant, a direct-to-consumer insurance company, is participating in this funding round. Their involvement suggests a strategic interest in companies leveraging advanced technology for broad market application.
SquareOne Venture Capital
SquareOne Venture Capital, an early-stage investor focused on B2B tech, is backing Ultralytics. Their investment highlights a belief in Ultralytics's foundational technology and its potential for significant market disruption.
What's next for Ultralytics?
With this recent major strategic investment, Ultralytics is poised for accelerated growth and further innovation in the rapidly evolving AI landscape. The company's focus on enhancing its YOLO framework and expanding its suite of computer vision solutions is expected to drive deeper integration across various industries. This funding will likely support expanded research and development efforts, bolster its global community engagement, and solidify its market leadership in providing accessible, high-performance AI tools for object detection and beyond. The enterprise-level backing signals strong confidence in Ultralytics's long-term vision and its capacity to deliver impactful AI solutions.
See full Ultralytics company page
